Most Downloaded Articles

Gleason Score Correlation Between Prostate Biopsy and Radical Prostatectomy Specimens
  • Erdem Öztürk
  • Taha Numan Yıkılmaz
Bull Urooncol 2018; 17: 1-4 DOI: 10.4274/uob.921
Experimental animal models for bladder cancer
  • Sevket Tolga Tombul
  • Talha Müezzinoglu
Bull Urooncol 2013; 12: 50-53
Radiation therapy for bladder cancer
  • Ömür Karakoyun Çelik
  • Fatma Sert
Bull Urooncol 2012; 11: 70-73
Active Surveillance in Prostate Cancer
  • Volkan İzol
  • Nebil Akdoğan
Bull Urooncol 2017; 16: 127-132 DOI: 10.4274/uob.820
2017 Author Index
Bull Urooncol 2017; 16: 0-0
Comparison of Subcapsular and Total Orchiectomy in Patients with Prostate Cancer
  • Taha Numan Yıkılmaz
  • Erdem Öztürk
  • Nurullah Hamidi
  • Halil Başar
Bull Urooncol 2018; 17: 5-8 DOI: 10.4274/uob.925
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
  • Serdar Çelik
  • Zekiye Sultan Altun
  • Safiye Aktaş
Bull Urooncol 2018; 17: 18-25 DOI: 10.4274/uob.947
What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?
  • Turgay Ebiloğlu
  • Engin Kaya
Bull Urooncol 2018; 17: 49-53 DOI: 10.4274/uob.970
Positron Emission Tomography in Renal Cell Carcinoma
  • Cigdem Soydal
  • Yüksel Ürün
Bull Urooncol 2018; 17: 68-72 DOI: 10.4274/uob.946
Oncocytic Adrenocortical Carcinoma: A Rare Case Report
  • Oktay Üçer
  • Oğuzcan Erbatu
  • Ayça Tan
  • Talha Müezzinoğlu
Bull Urooncol 2018; 17: 73-75 DOI: 10.4274/uob.975
Prostate cancer: New developments in pathogenesis and prognostic repercussions
  • Bora Gürel
Bull Urooncol 2013; 12: 279-284
Editorial
  • Talha Müezzinoglu
Bull Urooncol 2013; 12: 0-0
Open partial nephrectomy: recent situation
  • Iyimser Üre
  • Sinan Sözen
Bull Urooncol 2012; 11: 225-229
Hemostatic agents in open partial nephrectomy
  • Kemal Ener
  • Emrah Okulu
  • Önder Kayigil
Bull Urooncol 2012; 11: 230-233
Approach to the complications of intravesical therapy in bladder cancer
  • Turgay Gülecen
  • Cüneyd Özkürkçügil
Bull Urooncol 2012; 11: 34-40
Active surveillance of small renal masses: progression patterns of early stage kidney cancer
  • Nursen Atasoy
  • Semih Ayan
Bull Urooncol 2011; 10: 102-103
Flüoresan sistoskopi ve tur'un gelecegi var mi?
  • Gökhan Özer
Bull Urooncol 2011; 10: 26-30
  • Saadettin Eskiçorapçi
Bull Urooncol 2008; 7: 20-26
Fuhrman Nuclear Grading System Overview in Renal Cell Carcinoma
  • Oguz Özden Cebeci
  • Tayyar Alp Özkan
  • Ahmet Tugrul Eruyar
Bull Urooncol 2014; 13: 157-160 DOI: 10.4274/uob.107
Morphologic and Molecular Charecteristics of Renal Tumors
  • Sait Sen
Bull Urooncol 2015; 14: 278-284 DOI: 10.4274/uob.495
Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy
  • Ömer Burak Argun
  • Can Öbek
  • Ali Riza Kural
Bull Urooncol 2016; 15: 76-79 DOI: 10.4274/uob.635
The Clinical, Oncological, Functional and Surgical Outcomes of Patients Who Underwent Adrenalectomy
  • Ünsal Eroglu
  • Murat Yavuz Koparal
  • Iyimser Üre
  • Serhat Çetin
  • Ender Cem Bulut
  • Cenk Acar
  • Tevfik Sinan Sözen
Bull Urooncol 2016; 15: 129-135 DOI: 10.4274/uob.691
Incidentally Found Paratesticular Rhabdomyosarcoma: Case Report
  • Dr. Halil Çagri Aybal
  • Dr. Taha Numan Yikilmaz
  • Dr. Fatih Hizli
  • Dr. Halil Basar
  • Dr. Emin Taha Keskin
Bull Urooncol 2017; 16: 28-30 DOI: 10.4274/uob.720
Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
  • Elif Atag
  • Aziz Karaoglu
  • Ömer Küçük
Bull Urooncol 2017; 16: 57-62 DOI: 10.4274/uob.763
A Rare Case Mimicking Ureteral Stone or Tumor: Intraureteral Organized Debris
  • Ismail Selvi
  • Ali Ihsan Arik
  • Emin Taha Keskin
  • Mehmet Sinan Basay
  • Burcu Keles
Bull Urooncol 2017; 16: 63-66 DOI: 10.4274/uob.756
A Rare Presentation of Germ Cell Neoplasia: Persistant Müllerian Duct Syndrome
  • Alp Tuna Beksaç
  • Muhammet Irfan Dönmez
  • Çisel Aydin
  • Dilek Ertoy Baydar
  • Mustafa Sertaç Yazici
  • Ali Ergen
  • Bülent Akdogan
Bull Urooncol 2017; 16: 101-104 DOI: 10.4274/uob.825
Evaluation of the Relationship Between Duration of Smoking and Clinical and Pathologic Characteristics of Bladder Cancer at Diagnosis
  • Bora İrer
  • Filiz Dağ
  • Güven Aslan
Bull Urooncol 2017; 16: 108-111 DOI: 10.4274/uob.870
Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer?
  • Tümay İpekçi
  • Mustafa Yüksel
  • Murat Uçar
  • Ahmet Tunçkıran
  • Zafer Kozacıoğlu
  • Ramazan Yavuz Akman
Bull Urooncol 2017; 16: 119-122 DOI: 10.4274/uob.900
Editorial
  • Murat Koşan
Bull Urooncol 2017; 16: 0-0
Metastasis Targeted Therapies in Renal Cell Cancer
  • K. Fehmi Narter
  • Bora Özveren
Bull Urooncol 2018; 17: 26-32 DOI: 10.4274/uob.962
Reflection of Adjuvant Treatment Approaches for Early Stage Testis Tumors in Our Clinic
  • İsmail Selvi
  • Erdem Öztürk
  • Taha Numan Yıkılmaz
  • Nurullah Hamidi
  • Halil Başar
Bull Urooncol 2018; 17: 39-44 DOI: 10.4274/uob.973
Long-Term Outcomes of Patients Who Underwent Ureterocutaneostomy
  • Fuat Kızılay
  • Adnan Şimşir
  • İbrahim Cüreklibatır
  • Çağ Çal
Bull Urooncol 2018; 17: 54-58 DOI: 10.4274/uob.978
Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation
  • Reha Girgin
  • N. Aydın Mungan
Bull Urooncol 2018; 17: 63-67 DOI: 10.4274/uob.967
Wunderlich Syndrome, Tuberous Sclerosis-Related Giant Renal Angiomyolipoma Rupture: Case Report
  • Özer Baran
  • Aykut Aykaç
  • Serkan Öner
  • Alpay Aktümen
  • Salih Bürlukkara
  • Mehmet Melih Sunay
  • Hakkı Uğur Özok
Bull Urooncol 2018; 17: 76-78 DOI: 10.4274/uob.994
Ongoing Studies of the Bladder Tumor Study Group: An Overview
  • N. Aydin Mungan
  • Ilker Tinay
Bull Urooncol 2014; 13: 67-69 DOI: 10.4274/UOB.01
How Can One Define the Surgical Quality of Radical Cystectomy?
  • Mesut Altan
  • Burhan Özdemir
  • Burak Çitamak
  • Bu¨lent Akdogan
  • Haluk Özen
Bull Urooncol 2014; 13: 70-74 DOI: 10.4274/UOB.02
Surgical Approaches in Patients with Metastatic Bladder Cancer: Metastasectomy and Palliative Cystectomy
  • Utku Lokman
  • Özgu¨r Ugurlu
Bull Urooncol 2014; 13: 75-78 DOI: 10.4274/UOB.03
Approaches to Upper Urinary Tract Recurrences Following Radical Cystectomy
  • Mehmet Ilker Gökçe
  • Su¨mer Baltaci
Bull Urooncol 2014; 13: 79-83 DOI: 10.4274/UOB.04
Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome
  • Polat Tu¨rker
Bull Urooncol 2014; 13: 84-87 DOI: 10.4274/UOB.05
Transurethral Resection of Bladder Cancer (TUR-B) for Non-Muscle Invasive Bladder Cancer: How to Reach Excellence?
  • Mehmet Ilker Gökçe
  • Yasar Bedu¨k
Bull Urooncol 2014; 13: 88-92 DOI: 10.4274/UOB.06
Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?
  • Ali Furkan Batur
  • Sinan Sözen
Bull Urooncol 2014; 13: 93-98 DOI: 10.4274/UOB.07
Is Lymphadenectomy Necessary in the Surgical Treatment of Upper Urinary Tract Urothelial Carcinoma?
  • Yakup Kordan
  • Onur Kaygisiz
Bull Urooncol 2014; 13: 99-102 DOI: 10.4274/UOB.08
The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?
  • Polat Tu¨rker
  • Levent Tu¨rkeri
Bull Urooncol 2014; 13: 103-108 DOI: 10.4274/UOB.09
Does Urinary Cytology Find the Value in the Detection and Follow-up of Urinary Bladder Cancer?
  • Kutsal Yöru¨koglu
Bull Urooncol 2014; 13: 109-112 DOI: 10.4274/UOB.10
Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis of Patients with Non-Muscle Invasive Bladder Cancer: A Review Based on Meta-Analysis
  • Emre Tu¨zel
Bull Urooncol 2014; 13: 113-118 DOI: 10.4274/UOB.11
Bladder Perforation During TUR of Non Muscle Invasive Bladder Tumours: Early and Late Management
  • Deniz Arslan
Bull Urooncol 2014; 13: 119-121 DOI: 10.4274/UOB.12
Current Status of Laparoscopic Radical Nephroureterectomy in the Treatment Modalities for Upper Urinary Tract Tumors
  • Ahmet Gu¨deloglu
  • Cenk Yu¨cel Bilen
Bull Urooncol 2014; 13: 122-126 DOI: 10.4274/UOB.13
Metabolic syndrome in the etiology of benign prostatic hyperplasia/ lower urinary tract symptoms
  • Polat Türker
  • Cenk M. Yazici
Bull Urooncol 2013; 12: 227-231
The current status of prostate-specific antigen in the management of Benign Prostatic Hyperplasia
  • Ali Tekin
Bull Urooncol 2013; 12: 232-236
Urodynamic studies in Benign Prostate Hyperplasia: whom and when?
  • Umut Gönülalan
  • Murat Kosan
Bull Urooncol 2013; 12: 237-241

About Journal

Forms

Useful Links

Applications